Work

Targeting the CD38-NAD⁺ axis alleviates antibody-driven cytopenia in autoimmune disorders without inducing broad immunosuppression

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417018489
Cites:
Cited by: 1
Related to: